2025 Antiobesity Market Outlook: Key Indicators Shaping Growth Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Antiobesity Industry Market Size Be by 2025?
In recent times, the antiobesity market has significantly grown in size. From $3.74 billion in 2024, it is projected to expand to $4.1 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.7%. The historical growth of this market can be traced back to a rise in obesity prevalence, enhanced awareness and education, alterations in lifestyle, and government initiatives.

What's the Long-Term Growth Forecast for the Antiobesity Market Size Through 2029?
In the coming years, the antiobesity market is predicted to experience substantial growth, reaching a valuation of "$5.94 billion by 2029 with a compound annual growth rate (CAGR) of 9.7%. The surge in growth during the forecast period can be credited to factors like market enlargement and globalization. Key trends observed during this timeframe encompass progress in research and development, emphasis on patient-centered strategies, insurance coverage expansion, technological progress, the rise of digital health and telemedicine, new drug treatments, advancements in bariatric surgery, over-the-counter (otc) solutions, behavioral tactics, as well as the advent of nutritional and weight management apps.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report

What Are the Key Growth Drivers Fueling the Antiobesity Market Expansion?
Worldwide, obesity is a significant public health issue that's receiving increasing attention. Emphasizing this point, the World Obesity Atlas, a well-known organization based in the UK, pointed out in May 2022 that the worldwide frequency of obesity is rising annually. The organization predicts that by 2030, over one billion individuals around the world will be classified as obese. Factors such as the increasing intake of processed and unhealthy foods, sedentary lifestyles, and limited understanding of obesity-related risks are key contributors to this increasing prevalence. Consequently, these circumstances are likely to propel a surge in the demand for anti-obesity medications, eventually stimulating market growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp

What Are the Key Trends Driving Antiobesity Market Growth?
In the anti-obesity drugs market, leading companies are shifting their focus towards the creation of innovative products like Mounjaro (tirzepatide) to ensure efficacious services for the customers. Mounjaro (tirzepatide) serves as a reliable medication for adults suffering from obesity or weight-related health conditions. For example, in October 2022, the US pharmaceutical firm, Eli Lilly and Company, introduced Mounjaro (tirzepatide), which was sanctioned by the US Food and Drug Administration (FDA) as a fast-tracked treatment solution. Mounjaro (tirzepatide) comes in an injectable form, assisting those dealing with obesity to meet their weight loss objectives. Prescribed usually to adults with type 2 diabetes, it is used in conjunction with diet and exercise to manage blood sugar (glucose) levels.

How Is the Antiobesity Market Segmented?
The antiobesity market covered in this report is segmented -

1) By Drug Class: Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs
2) By Type: Prescription Drugs (Rx), OTC Drugs
3) By Medication: Monotherapies, Polytherapies

Subsegments:
1) By Peripherally Acting Anti-Obesity Drugs: Orlistat, Lorcaserin
2) By Centrally Acting Anti-Obesity Drugs: Phentermine, Topiramate, Naltrexone-Bupropion Combination, Liraglutide

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3403&type=smp

Which Companies Are Leading the Charge in Antiobesity Market Innovation?
Major companies operating in the antiobesity market include F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Novartis International AG, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Allergan Aesthetics, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Intas Pharmaceuticals Ltd., Wockhardt Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd.

Which Regions Are Leading the Global Antiobesity Market in Revenue?
North America was the largest region in the anti-obesity market in 2024. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3403

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Reach Out to Us
Speak With Our Expert:Saumya Sahay,
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.